Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05853939 · ClinicalTrials.gov registry record · NA

Measuring rTMS-induced Neuroplasticity With EEG Steady-state Visual-evoked Potentials

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT05853939 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 106 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05853939, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

The goals of this study are to 1) use EEG steady-state visual evoked potentials as a noninvasive measure of the neuroplasticity induced by repetitive transcranial magnetic stimulation (rTMS), 2) use visual contrast detection paradigms as a behavioral measure of rTMS effects, and 3) to investigate how visual spatial attention augments or suppresses the neuroplastic impact of rTMS. Participants will observe visual stimuli on a screen while allocating their attention to different parts of the visual field and making responses when they observe changes in the visual stimuli. rTMS is performed to visual cortex using MRI-retinotopy neuronavigation. Then the visual task paradigm is performed again.

Interventions

  • DEVICE repetitive transcranial magnetic stimulation

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2023-07-01
Est. Completion 2026-06-02
Phase NA

What the Registry Record Tells You About NCT05853939

The ClinicalTrials.gov registry entry for NCT05853939 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which repetitive transcranial magnetic stimulation is the first listed.

NCT05853939 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05853939 about?

NCT05853939 is a clinical study titled "Measuring rTMS-induced Neuroplasticity With EEG Steady-state Visual-evoked Potentials". The goals of this study are to 1) use EEG steady-state visual evoked potentials as a noninvasive measure of the neuroplasticity induced by repetitive transcranial magnetic stimulation (rTMS), 2) use visual contrast detection paradigms as a behavioral measure of rTMS effects, and 3) to investigate ho...

What is the current status of trial NCT05853939?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2023-07-01. Estimated completion is 2026-06-02.

What interventions are being tested in trial NCT05853939?

The interventions under investigation include: repetitive transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT05853939?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.